The present study also showed that despite an increase in the FGF23 serum level in the studied thalassemia patients affected by hypoparathyroidism and hyperphosphatemia, no rise in the urinary phosphate excretion was observed. The gene discussed is FGF23; the disease is hyperphosphatemia.